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Abstract
Background: We studied the incidence of tuberculosis, AIDS, AIDS deaths and AIDS-TB co-infection at the population level
in Rio de Janeiro, Brazil where universal and free access to combination antiretroviral therapy has been available since 1997.
Methodology/Principal Findings: This was a retrospective surveillance database match of Rio de Janeiro databases from
1995–2004. Proportions of tuberculosis occurring within 30 days and between 30 days and 1 year after AIDS diagnosis were
determined. Generalized additive models fitted with cubic splines with appropriate estimating methods were used to
describe rates and proportions over time. Overall, 90,806 tuberculosis cases and 16,891 AIDS cases were reported; 3,125
tuberculosis cases within 1 year of AIDS diagnosis were detected. Tuberculosis notification rates decreased after 1997 from a
fitted rate (fR per 100,000) of 166.5 to 138.8 in 2004. AIDS incidence rates increased 26% between 1995 and 1998 (30.7 to
38.7) followed by a 33.3% decrease to 25.8 in 2004. AIDS mortality rates decreased dramatically after antiretroviral therapy
was introduced between 1995 (27.5) and 1999 (13.4). The fitted proportion (fP) of patients with tuberculosis diagnosed
within one year of AIDS decreased from 1995 (24.4%) to1998 (15.2%), remaining stable since. Seventy-five percent of
tuberculosis diagnoses after an AIDS diagnosis occurred within 30 days of AIDS diagnosis.
Conclusions/Significance: Our results suggest that while combination ART should be considered an essential component of
the response to the HIV and HIV/tuberculosis epidemics, it may not be sufficient alone to prevent progression from latent
TB to active disease among HIV-infected populations. When tuberculosis is diagnosed prior to or at the same time as AIDS
and ART has not yet been initiated, then ART is ineffective as a tuberculosis prevention strategy for these patients. Earlier
HIV/AIDS diagnosis and ART initiation may reduce TB incidence in HIV/AIDS patients. More specific interventions will be
required if HIV-related tuberculosis incidence is to continue to decline.
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Introduction
The impact of the human immunodeficiency virus/acquired
immune deficiency syndrome (HIV/AIDS) epidemic on tubercu-
losis (TB) incidence has been catastrophic, underscoring the need
for new approaches to controlling these overlapping diseases [1,2].
Cohort studies [3–10] have shown that combination antiretroviral
therapy (ART) reduces the risk of active tuberculosis in individuals
compared to no treatment, but the ecological level impact of ART
on tuberculosis rates is not yet known.
In Brazil, antiretrovirals have been available free of charge for
HIV patients since 1991 and combination therapy including
protease inhibitors since 1997. Rio de Janeiro presents a unique
setting to evaluate the population level impact of ART on the
incidence of HIV-related tuberculosis. If combination ART
significantly reduces active tuberculosis incidence among popula-
tions with HIV/AIDS, then the global scale up of HIV therapy
could contribute to improved tuberculosis control. Conversely, the
lack of an appreciable effect would suggest that alternative
strategies are needed.
We studied the incidence of active tuberculosis, AIDS, AIDS
deaths and tuberculosis with AIDS in the same year in Rio de
Janeiro from 1995–2004 using surveillance databases maintained
by the City Health Secretariat. Reporting of tuberculosis and
AIDS is mandatory, and both ART and anti-tuberculosis drugs
are distributed exclusively by the government. By measuring rates
of both tuberculosis and AIDS in the population of an entire large
city, we would be able to assess trends in AIDS-related tuberculosis
in the era of combination antiretroviral therapy.
Methods
Three official databases (described below) of the City Health
Secretariat of Rio de Janeiro were used to determine total number
of AIDS cases, tuberculosis cases, AIDS deaths and AIDS/
tuberculosis cases between 1995 and 2004, and the annual
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tuberculosis cases reported to the Health Department (The
Sistema de Informac ¸a ˜o de Agravos de Notificac ¸a ˜o – AIDS and
Tuberculosis [SINAN – AIDS and SINAN-TB] and the Sistema
de Informac ¸a ˜o sobre Mortalidade [SIM]) are Brazilian nation-
wide mandatory reporting systems for AIDS, tuberculosis, and
deaths, respectively. The AIDS data have been maintained in an
electronic database in the City Health Department since the first
AIDS case was reported in 1982, as has been the situation for
tuberculosis cases reported since 1995 and for deaths since 1979.
Patients are included in databases when they are diagnosed with
either AIDS or tuberculosis according to the Brazilian guidelines
at the time of diagnosis. Information collected includes demo-
graphic and specific clinical information, including name, date of
birth, mother’s name and date of diagnosis. The forms are
completed by a health professional in a primary care unit or in a
hospital on the day the individual is diagnosed with the disease.
The forms are then sent to the City Health Department and
entered into a main electronic database, developed by the
Brazilian Ministry of Health. Information on mortality is also
kept in an electronic database and is based on the death certificate,
completed by the attending physician at the time of death. In
Brazil, tuberculosis is diagnosed in patients presenting with signs
and symptoms compatible with tuberculosis on the basis of chest
radiographs, sputum acid-fast bacilli smears, and response to anti-
tuberculosis therapy [11,12]. An AIDS diagnosis is based on
clinical and/or immunological criteria as in the WHO definition
[13]. However, tuberculosis is not necessarily an AIDS defining
illness in HIV-infected persons in Brazil, but contributes a score of
5 in a 10 point scale required for an AIDS diagnosis [14].
In order to identify tuberculosis cases among AIDS patients,
both the information about tuberculosis at the time of notification
and a database linkage between AIDS and tuberculosis databases
was performed. The primary components of the matching
algorithm were patient name (last and first), mother’s name, and
date-of-birth. Briefly, a hierarchical algorithm combining an
adaptation of the Soundex phonetic algorithm to the Portuguese
language and a similarity score for strings implemented in the
library difflib from Python [15] was used to determine the degree
of similarity between records in the databases. Pairs of records
were classified as a true match, a non-match, and, when the
algorithm was not able to determine the status automatically,
records were checked manually. Preliminary results of the linkage
algorithm, performed with patients in two large HIV-infected
cohorts in Rio de Janeiro and the mortality database, indicated
that the algorithm has high sensitivity (,92%) and specificity
(,99%) to detect true matches. The algorithm was written in
Python for Windows version 2.4 [15].
Patients were considered to have tuberculosis at the same time as
their AIDS diagnosis if they either had tuberculosis mentioned in
their AIDS report form or if they had a tuberculosis episode found
through linkage up to 30 days before AIDS diagnosis. In another
definition, we also included those who had tuberculosis up to 30
days after AIDS diagnosis as having tuberculosis at AIDS diagnosis.
These definitions were necessary because the surveillance systems
are separate and so are physicians who report AIDS and/or
tuberculosis, evenin the same heath care facility,and small delaysin
reportingone orthe otherconditionisexpected.Thetwodefinitions
were combined to provide the number of simultaneous diagnoses.
Analysis
To determine the proportion of AIDS patients who were
diagnosed with tuberculosis within one year following their AIDS
diagnosis, annual cohorts of patients diagnosed with AIDS in a
calendar year were defined as denominators with tuberculosis
diagnosed within up to one year since AIDS diagnosis among this
population as numerators. Municipal surveillance estimates of
number of AIDS patients receiving combination ART have been
used to overlay graphs generated for this analysis. Generalized
additive models (GAM) [16] were used to adjust the incidences and
proportions along with 95% confidence intervals (CI). All models
used cubic splines with 3 knots and quasipoisson and quasibinomial
familieswere used forratesandproportions, respectively, toaccount
forwithin-yearcorrelation.ProportionsofAIDS-TB casesovertime
werecalculatedfrom1995and2003only,inordertoallow 1yearto
accrue tuberculosis cases among them. Separate analyses were
carried out for those who had tuberculosis within 30 days from
AIDS diagnosis (considered as tuberculosis at AIDS diagnosis) and
those who had it between 30 days and one year. These separate
analyses were conducted to describe trends in prevalent tuberculosis
disease (simultaneous diagnoses) and incident disease (diagnosed
between 30 days and one year following AIDS diagnosis). All
analyses were done with R for Windows version 2.4.1 [17].
Results
Between 1995 and 2004, 90,806 tuberculosis cases and 16,891
AIDS cases were reported in Rio de Janeiro. Initially, the AIDS
registry listed 2,160 patients with a concurrent tuberculosis
diagnosis. The 90,806 patients recorded in the tuberculosis
registry were merged with 14,371 AIDS patients who did not
have tuberculosis reported at AIDS diagnosis. This merge yielded
an additional 1,962 coinfected cases. After comparing the registries
and removing duplicates and recurrences, we found 3,125 AIDS
cases who had one tuberculosis episode within one year of AIDS
reporting, with 2,436 diagnosed within the first 30 days and 689
between 30 days and one year. The 3,125 tuberculosis episodes
within one year of AIDS notification between 1995 and 2003
constituted 3.45% of all tuberculosis patients and 18.5% of all
AIDS patients during that time.
Tuberculosis notification rates (Figure 1) had a slight increase
from 1995–1997, and then decreased 16.6% between 1997 and
2004 from a fitted rate of 166.5 per 100,000 person-years
(95%CI=161.6, 167.2) to a fitted rate of 138.8 (95%CI=135.1,
142.6). Figure 2 displays the increasing AIDS incidence rates
between 1995 and 1998 (26% in fitted rates from 30.7 to 38.7)
followed by a 33.3% decrease to 25.8 (95%CI=22.9, 28.7) in
2004. Figure 2 also illustrates the dramatic reduction in AIDS
mortality after ART was introduced from 1,537 deaths (fitted
rate=27.5; 95%CI=25.7,29.2) in 1995 to 769 deaths (fitted
rate=13.4; 95%CI=12.3,14.6) in 1999.
The proportion of patients with tuberculosis diagnosed within
one year of AIDS diagnosis (including those between 0 and 30 days)
over this time period is shown in Figure 3, along with the number of
patients receiving combined ART since 1997. The fitted proportion
of AIDS cases who had tuberculosis within one year of AIDS
diagnosis decreased from 24.4% in 1995 (95%CI=22.1, 26.6) to
15.2% in 1998 (95%CI=14.1, 16.3), remaining stable since then,
reaching 14.7% in 2003 (95%CI=12.9, 16.6). There has been no
significant change in AIDS mortality rates since 1999 or
tuberculosis proportion within 1 year of AIDS diagnosis since
1998, despite the threefold increase in combined ART (from 7,297
patients in 1997 to 20,749 patients in 2004).
In Figure 4, the proportion of tuberculosis cases diagnosed
within 30 days of AIDS diagnosis is shown (open circles) along
with the proportion of tuberculosis cases diagnosed between 30
days and 1 year after AIDS diagnosis (open triangles). From these
graphs, it is evident that the majority of coinfected patients (75%)
AIDS/TB in Rio de Janeiro
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Proportions have steadily decreased among those diagnosed within
30 days of their AIDS diagnosis, from 18.2% in 1995
(95%CI=16.5, 19.9) to 11.7% in 1998 (95%CI=10.9, 12.5),
remaining stable since then with a fitted proportion of 12.0% in
2003 (95%CI=10.5, 13.5). The proportions of patients diagnosed
with tuberculosis between 30 days and 1 year after their AIDS
diagnosis also decreased from 6.2% (95%CI=5.2, 7.2) in 1995 to
3.5% (95%CI=3.1, 4.0) in 1998, with a continued slight decrease
thereafter, reaching 2.7% in 2003 (95%CI=2.1, 3.3).
Discussion
The population burden of AIDS-related tuberculosis in Rio de
Janeiro decreased significantly between 1995 and 1998, however
little change occurred between 1998 and 2003 despite the
widespread increased distribution of HAART for AIDS patients
during this time. Active tuberculosis notification rates have been
steadily decreasing in Rio de Janeiro as has overall AIDS incidence.
AIDS mortality has also been stable since 1999 despite the increase
in HAART distribution. Though the proportion of patients
developing tuberculosis after AIDS declined between 1993 and
2002,themagnitudeofdecreasewassubstantiallylessthanthat seen
with other opportunistic infections, such as pneumocystis pneumo-
nia and toxoplasmosis [18] and the proportion of AIDS patients
who were later diagnosed with tuberculosis remained stable.
Moreover, the majority (75%) of active tuberculosis cases diagnosed
among AIDS patients was diagnosed within 30 days of AIDS
diagnosis and there wasno significant reductionin the proportion of
tuberculosis cases diagnosed within 30 days of an AIDS diagnosis
Figure 1. Tuberculosis notification rates, fitted rates and 95% confidence intervals in Rio de Janeiro between 1995 and 2004.
doi:10.1371/journal.pone.0003132.g001
Figure 2. AIDS incidence rates (open triangles) and AIDS death rates (crosses) with fitted rates and 95% confidence intervals in Rio
de Janeiro between 1995 and 2004.
doi:10.1371/journal.pone.0003132.g002
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between 30 days and 1 year of an AIDS diagnosis, only moderate
overall reductions in tuberculosis diagnoses were observed, even
though a negligible decrease in the proportions was also observed
after 1998.
Overall AIDS mortality in Rio de Janeiro fell by 50% from
1995 to 1999, remaining somewhat stable since then. Beginning in
1997, combined antiretroviral use in Rio de Janeiro increased
substantially. The declining trend in mortality in Brazil before the
widespread availability of HAART was well documented both at
the individual level [19] and at the population level [20] and could
be attributed to the universal availability of other therapeutic
schemes, and the protection of ART on TB-AIDS co-infection
must have followed the same trend. Thus, the most plausible
explanation for not finding a reduction in tuberculosis after AIDS
is that in Rio de Janeiro a high proportion of the population has
latent tuberculosis and, therefore, tuberculosis occurs before HIV-
infected. patients meet criteria for, or gain access to, ART.
Another explanation would be delays in HIV diagnosis, leading
patients to be diagnosed when they get tuberculosis diagnosed
together with other criteria for AIDS definition. Our data shows
that 75% of AIDS patients with active tuberculosis are actually
being diagnosed with tuberculosis at the same time or soon after
AIDS diagnosis when antiretroviral therapy would be initiated.
Modeling suggests that ART will result in greater reductions in
tuberculosis incidence if started at CD4 cell counts of 500 cells/ml
[21], but guidelines in Brazil and most countries recommend
initiating treatment later [11].
Figure 3. Proportions of AIDS-TB within one year of AIDS diagnosis (open triangles) with fitted proportions and 95% confidence
intervals between 1995 and 2003 and number of patients receiving combination ART (open circles) between 1995 and 2004 in Rio
de Janeiro.
doi:10.1371/journal.pone.0003132.g003
Figure 4. Proportion of AIDS-TB within 30 days of AIDS diagnosis (open circles) and between 30 days and one year (open triangles)
with fitted proportions and 95% confidence intervals between 1995 and 2003 in Rio de Janeiro.
doi:10.1371/journal.pone.0003132.g004
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Janeiro occurred during the study period. First, in 1995, the
definition was modified to include as an AIDS diagnosis any death
certificate that mentioned AIDS as a basic cause of death. This
was not previously done and is likely the reason for increased
incidence of AIDS/tuberculosis co-infection between 1995 and
1996. Many AIDS patients die from tuberculosis and prior to
1996, a co-infected patient who died, but had not been reported to
the Health Department as AIDS would have been counted only as
a co-infection death, but not an AIDS case. This measure aimed to
increase coverage of the surveillance system and in fact increased
the amount of AIDS incidence in Brazil.
A second significant change in the AIDS definition in Rio de
Janeiro occurred during the study period in 1998. At this time
patients who were HIV infected and had a CD4 count ,350 were
considered to have AIDS. The number of AIDS cases peaked in
1998 in response to the definition change. If the change in
definition had not occurred, it is likely that proportion trends
would have stabilized beginning in 1997, rather than 1998. The
potential effectiveness of ART in reducing tuberculosis incidence
appears to have been relatively unfazed by this definition change.
However, the proportion of AIDS patients diagnosed with
tuberculosis within one year of AIDS diagnosis has been relatively
stable for quite some time. Thus, it is possible that there is a limit
to the effectiveness of antiretroviral therapy in reducing tubercu-
losis incidence at the population level.
The proportion of AIDS patients diagnosed with tuberculosis
dropped substantially during the first several years of the study
period, while the number of coinfected cases decreased markedly
throughout the entire study period. Thus, it is likely that combined
ART use influenced the overall decrease in tuberculosis incidence
during the study period, or, at the very least helped prevent steep
increases in tuberculosis incidence that would have otherwise
occurred. AIDS-related tuberculosis in Rio de Janeiro decreased
during the study period, whereas it increased in other countries
with high rates of co-infection where ART was not available [1].
The observed stability of the proportion of AIDS patients
developing tuberculosis since 1998 suggests that while combina-
tion ART should be considered an essential component of the
response to the HIV and HIV / tuberculosis epidemics, it may not
be sufficient alone to control tuberculosis among HIV-infected
populations. Our results suggest that more specific interventions
will be required if HIV-related tuberculosis incidence is to
continue to decline.
A limitation in this study is that the linkage was conducted with
the AIDS registry rather than an HIV registry because HIV is not
a reportable infection in Brazil. Even though our analysis may
underestimate the true burden of co-infection among HIV-
infected patients, similar trends in co-infection are observed when
we included tuberculosis cases diagnosed between one and three
years prior to AIDS diagnosis (data not shown). It is likely that
tuberculosis diagnosed within 1 year, and possibly up to three
years, prior to an AIDS diagnosis represents HIV-TB co-infection.
Thus, even though inclusion in our analysis relies on an AIDS
diagnosis, it is likely that our data closely resemble HIV-TB co-
infection.
A second limitation is the ecologic approach of investigating the
association between decreasing co-infection and increased usage of
antiretroviral therapy, in which associations should be seen with
caution, since this kind of approach lacks a causal chain of events
and could lead to the so-called ecologic fallacy. We did not link
individual patient data with antiretroviral data, thus conclusions
based on these analyses are primarily based on observation of
trends in disease and number of patients receiving ART. Even
though we do not have direct measures of HAART coverage in
Brazil, we believe that it is high, since by law the government is
obligated to provide free medication to all patients eligible for
treatment according to Brazilian guidelines. Antiretroviral therapy
has been shown to effectively reduce risk of tuberculosis in HIV-
infected patients in cohort studies [6], thus extrapolation to
population level data would be expected to yield similar trends.
Our data suggest that antiretroviral therapy, when distributed to
a large proportion of the HIV-infected population, reduces the
incidence of tuberculosis. However, tuberculosis remains a
common problem, with 15% of AIDS cases experiencing and
episode of tuberculosis in the year following diagnosis, most within
30 days. Because tuberculosis is so often an early complication of
HIV, many patients will not have been given ART prior to
becoming ill with tuberculosis. Further interventions are necessary
to significantly reduce the tuberculosis burden among HIV-
infected persons. Treatment of latent tuberculosis infection among
HIV-infected patients [20,21] and active tuberculosis case finding
are strategies for potentially reducing tuberculosis/HIV burden.
These and other interventions should be assessed to determine
their effects in controlling tuberculosis in settings where ART use
is being expanded.
Author Contributions
Conceived and designed the experiments: AGP RC JEG. Analyzed the
data: AGP RDM LM JEG. Contributed reagents/materials/analysis tools:
BD SCC LML RDM LM. Wrote the paper: AGP JEG.
References
1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, et al. (2003) The
growing burden of tuberculosis: global trends and interactions with the HIV
epidemic. Arch Intern Med 163: 1009–1021.
2. De Cock KM, Chaisson RE (1999) Will DOTS do it? A reappraisal of
tuberculosis control in countries with high rates of HIV infection. Int J Tuberc
Lung Dis 3: 457–465.
3. Badri M, Wilson D, Wood R (2002) Effect of highly active antiretroviral therapy
on incidence of tuberculosis in South Africa: a cohort study. Lancet 359:
2059–2064.
4. Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, et al. (2007) Reducing
tuberculosis incidence by tuberculin skin testing, preventive treatment, and
antiretroviral therapy in an area of low tuberculosis transmission. Clin Infect Dis
44: 94–102.
5. Girardi E, Antonucci G, Vanacore P, Libanore M, Errante I, et al. (2000)
Impact of combination antiretroviral therapy on the risk of tuberculosis among
persons with HIV infection. AIDS 14: 1985–1991.
6. Golub JE, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, et al. (2007)
The impact of antiretroviral therapy and isoniazid preventive therapy on
tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil. AIDS
21: 1441–1448.
7. Jones JL, Hanson DL, Dworkin MS, DeCock KM (2000) HIV-associated
tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent
Spectrum of HIV Disease Group. Int J Tuberc Lung Dis 4: 1026–1031.
8. Lawn SD, Myer L, Bekker LG, Wood R (2006) Burden of tuberculosis in an
antiretroviral treatment programme in sub-Saharan Africa: impact on treatment
outcomes and implications for tuberculosis control. AIDS 20: 1605–1612.
9. Santoro-Lopes G, de Pinho AM, Harrison LH, Schechter M (2002) Reduced
risk of tuberculosis among Brazilian patients with advanced human immuno-
deficiency virus infection treated with highly active antiretroviral therapy. Clin
Infect Dis 34: 543–546.
10. Miranda A, Morgan M, Jamal L, Laserson K, Barreira D, et al. (2007) Impact of
antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience,
1995–2001. PLoS ONE 2: e826.
11. Castelo Filho A, Kritski AL, Barreto AW, Lemos ACM, Netto AR, et al. (2004)
II Brazilian consensus on treatment of tuberculosis - Brazilian guidelines for
tuberculosis 2004 [In Portuguese]. J Bras Pneumol 30 (Suppl. 2): S62–S64.
12. World Health Organization, International Union Against Tuberculosis and
Lung Disease, Royal Netherlands Tuberculosis Association (2001) Revised
international defintions in tuberculosis control. Int J Tuberc Lung Dis 5:
213–215.
AIDS/TB in Rio de Janeiro
PLoS ONE | www.plosone.org 5 September 2008 | Volume 3 | Issue 9 | e313213. World Health Organization (2007) WHO Case Definitions of HIV for
Surveillance and Revised Clinical Staging and Immunological Classification of
HIV-Related Disease in Adults and Children.
14. Ministe ´rio da Sau ´de - Secretaria de Vigila ˆncia em Sau ´de - Programa Nacional
de DST e Aids (2006) Recomendac ¸o ˜es para Terapia Anti-Retroviral em Adultos
e Adolescentes Infectados pelo HIV.
15. Lutz M (2006) Programming Python. Sebastopol, CA: O’Reilly.
16. Hastie T, Tibshirani R (1990) Generalized additive models. New York:
Chapman and Hall.
17. R Development Core Team (2006) R: A language and environment for
statistical computing. Vienna, Austria: Foundation for Statistical Computing.
18. Soares EC, Saraceni V, Lauria LM, Pacheco AG, Durovni B, et al. (2006)
Tuberculosis as a disease defining acquired immunodeficiency syndrome: ten
years of surveillance in Rio de Janeiro, Brazil. J Bras Pneumol 32: 444–448.
19. Marins JR, Jamal LF, Chen SY, Barros MB, Hudes ES, et al. (2003) Dramatic
improvement in survival among adult Brazilian AIDS patients. AIDS 17:
1675–1682.
20. Brito AM, Castilho EA, Szwarcwald CL (2005) Regional patterns of the
temporal evolution of the AIDS epidemic in Brazil following the introduction of
antiretroviral therapy. Braz J Infect Dis 9: 9–19.
21. Williams BG, Dye C (2003) Antiretroviral drugs for tuberculosis control in the
era of HIV/AIDS. Science 301: 1535–1537.
AIDS/TB in Rio de Janeiro
PLoS ONE | www.plosone.org 6 September 2008 | Volume 3 | Issue 9 | e3132